$189 Million is the total value of Atlas Venture Advisors, Inc.'s 5 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CBLK | New | CARBON BLACK INC | $131,826,000 | – | 9,823,103 | +100.0% | 69.58% | – |
| TBIO | New | TRANSLATE BIO INC | $29,415,000 | – | 3,922,008 | +100.0% | 15.52% | – |
| ZFGN | New | ZAFGEN INC | $17,356,000 | – | 3,506,207 | +100.0% | 9.16% | – |
| MGEN | New | MIRAGEN THERAPEUTICS INC | $9,522,000 | – | 3,142,580 | +100.0% | 5.03% | – |
| SNAP | New | SNAP INCcl a | $1,350,000 | – | 245,076 | +100.0% | 0.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SNAP INC | 20 | Q3 2023 | 6.1% |
| ROKU INC | 16 | Q3 2023 | 11.7% |
| LARIMAR THERAPEUTICS INC | 14 | Q3 2023 | 1.4% |
| TRANSLATE BIO INC | 11 | Q2 2021 | 52.9% |
| INTEGRAL AD SCIENCE HLDNG CO | 10 | Q3 2023 | 71.2% |
| BICYCLE THERAPEUTICS PLC | 10 | Q3 2021 | 25.2% |
| VIRIDIAN THERAPEUTICS INC | 10 | Q1 2023 | 2.1% |
| F-STAR THERAPEUTICS INC | 9 | Q4 2022 | 1.3% |
| DRAFTKINGS INC | 8 | Q1 2022 | 82.5% |
| MIRAGEN THERAPEUTICS INC | 8 | Q3 2020 | 5.0% |
View Atlas Venture Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-01-27 |
View Atlas Venture Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.